Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to 0.4.

  • Cumberland Pharmaceuticals' Equity Ratio rose 2276.48% to 0.4 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.4, marking a year-over-year increase of 2276.48%. This contributed to the annual value of 0.3 for FY2024, which is 1647.62% down from last year.
  • Cumberland Pharmaceuticals' Equity Ratio amounted to 0.4 in Q3 2025, which was up 2276.48% from 0.41 recorded in Q2 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Equity Ratio peaked at 0.54 during Q2 2021, and registered a low of 0.3 during Q4 2024.
  • For the 5-year period, Cumberland Pharmaceuticals' Equity Ratio averaged around 0.41, with its median value being 0.41 (2023).
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Equity Ratio tumbled by 2301.09% in 2022, and later soared by 2282.76% in 2025.
  • Cumberland Pharmaceuticals' Equity Ratio (Quarter) stood at 0.51 in 2021, then dropped by 23.01% to 0.39 in 2022, then decreased by 7.24% to 0.36 in 2023, then dropped by 16.48% to 0.3 in 2024, then soared by 31.09% to 0.4 in 2025.
  • Its Equity Ratio was 0.4 in Q3 2025, compared to 0.41 in Q2 2025 and 0.41 in Q1 2025.